Jonathan Curio

#TreatTR @azeemlatib @AntonioMangieri @g_lanzillo @PCRonline @Ortega_Paz #EAPCI

“Innovators Day is not only for physicians.” In this interview with @CurioJonathan, @AndreaScotti21 explains how #PCRID brings together physicians, entrepreneurs, innovators and investors to discuss the future of cardiovascular innovation. 🚀🫀 #EuroPCR #PCRID

The 3 innovations competing for #EuroPCR 2️⃣0️⃣2️⃣6️⃣ #PCRID Innovators Day @PCRonline Jon DeHaan Foundation award nicely highlighted by @AndreaScotti21 ⤵️ ➡️Join #EuroPCR Ceremony on Thursday, 10:15, Main Arena, to learn the 200k grant winner @azeemlatib @nickaram @nicolo_piazza

A 1st row seat at the table w/ all key stakeholders - unique experience in Exchange Sessions at #EuroPCR #PCRID @PCRonline Innovators day ➡️Early stage funding, AI in innovation, late-stage reimbursement, Chinese innovation @AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza

Disrupting the aorta and valves: the next transcatheter wave 🔸ТТЗA - transcatheter ascending ao repair De Marco 🔸InFlow - polymeric transcatheter AV Buszman 🔸TriClover - TV clover repair De Bonis 🔸ReNiva Trapeze - posterior leaflet replacement Bapat #EuroPCR #PCRID

#treatTR beyond T-TEER vs. TTVR: 🎯M. deBonis w/ TriClover at #EuroPCR #PCRID @PCRonline 🎯 Transcath suture based tripple-orifice 🎯Reliable clover shape achieved in animals ➡️Design refinements & in-vivo/animal planned @AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza

Day 1 of #EuroPCR Week: #PCRID 2026 in Paris. 🌐Physicians, engineers, VCs, and entrepreneurs in the same room debating the future of cardiovascular innovation. 🏆Sessions on SH, HF, and venture capital, plus the Jon DeHaan Foundation Award for early-stage innovations.

#EuroPCR 2026 is here & yet has its 1st highlight: #PCRID @PCRonline Innovators Day💡 🎯Innovation shaping the future #IC field 🎯Tracks on paths from idea to FIH to clinical practice ➡️If in Paris, join at Palais Congres @AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza

Innovation is thriving in #interventionalcardiology, so make sure you follow the news from PCR Innovators Day, happening Monday 18 May in Paris. @CurioJonathan and @AndreaScotti21 will keep you up to date with all the buzz 🔥and hot news via their #PCRID #SoMe coverage! @azeemlatib @nickaram @nicolo_piazza #EuroPCR

🔥#ACC26 Late-breaking trials 🔥: TRISCEND II 🔗pcronline.com/News/Congress-… @CurioJonathan .provides his take ✍️on the results of this international, multi-centre, randomised, controlled trial that enrolled 400 patients with symptomatic severe TR. Presented by Vinod H. Thourani in New Orleans. #interventionalcardiology #clinicaltrial #cardioX

🔥#ACC26 Late-breaking trials 🔥: PRO-TAVI 🔗pcronline.com/News/Congress-… @CurioJonathan provides his take ✍️on this trial that evaluated whether deferral of routine PCI in patients undergoing TAVI is non-inferior in comparison to TAVI with preceding PCI, The results 📊 were presented by Michiel Voskuil in New Orleans and simultaneously published in @TheLancet. #interventionalcardiology #clinicaltrial #CardioX #TAVR

My Toolkit 🧰⚙️🪛:How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR 🔗pcronline.com/Cases-resource… Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR! @CurioJonathan & Matti Adam provide a step-by-step guide to navigate these complex redo cases. Reviewed by @parma. #interventionalcardiology #cardioX #medtwitter

Tricuspid regurgitation patients who receive TTVA with the Cardioband see positive cardiac remodeling and functional improvement a year post-procedure, according new a new German real-world study. Read more on #CRTonline. ow.ly/vWuk50XIyPV

#EIJonAir - Analysis of the NOTION-2 trial x.com/i/broadcasts/1…

Mild PVL after #TAVR is NO LONGER acceptable, especially in low/intermediate risk and younger patients. In #JACCINT @JACCJournals the OCEAN-TAVI registry showed long-term higher mortality and TAV failure even with mild PVL. Minimizing PVL when safe should be routine now. 2 seminar studies including one from our @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai by @ParasuramMD et al shows underexpanded balloon-expandable #TAVR risks early failure and ROUTINE DOUBLE-TAP post dilatation improves balloon-expandable TAV expansion! Like #PCI where you routinely pre-dilate a lesion and post dilate the stent to avoid ISR, and pre- and post-dilating in redo-PCI for ISR, optimizing valve frame expansion, minimizing PVL during index #TAVR is now paramount to confer durability, REGARDLESS of the type of TAV: balloon-expandable and self-expanding. Best view to do post-dilatation is at RAO CAU with TAV parallax removed to visualize the SHORT AXIS of the native annulus to evaluate frame geometry. WE MUST ACT NOW! OCEAN-TAVI registry on mild PVL and TAVR long-term outcomes jacc.org/doi/full/10.10… Editorial jacc.org/doi/full/10.10… Routine Double-Tap in SAPIEN 3 Ultra Resilia jacc.org/doi/10.1016/j.… Real-time Fluoroscopic analysis of underexpansion in balloon-expandable TAVR jacc.org/doi/full/10.10… Editorial jacc.org/doi/full/10.10…

Insights into PVL post #TTVR at #PCRLV ⬆️ @PamelaGatto @alcantaramonica @dr_chrisallen @O_Azizy_MD @BenekiEirini @MiChen__ @juliendreyfus1 @jcecharte @DrGarot @cvnurselin @drtsakamoto @a_sorropago @TagliariPaula @m_taramasso @dr_tyxiong

⭐New insights from TRIPLACE featured at #PCRLV: PVL after #TTVR by @AndreaScotti21 et al. 🎯 6.1% w/ >/= mod PVL (predicted by large RA, malpositioning, type IV morphology) 🎯>/= mod translated into ⬆️1y mort ➡️May have key implications for procedural optimization+device design

RV remodelling data post Lux #TTVR from #PCRLV ⬆️ @PamelaGatto @alcantaramonica @dr_chrisallen @O_Azizy_MD @BenekiEirini @MiChen__ @juliendreyfus1 @jcecharte @DrGarot @cvnurselin @drtsakamoto @a_sorropago @TagliariPaula @m_taramasso @dr_tyxiong

Latest Science for #treatTR featured at #PCRLV: RV remodelling after Lux- Valve #TTVR by Kobari et al. 🎯Sufficient+sustained TR reduction at 1y 🎯Translated into pos RV remodelling, espec in pt w/ TAPSE/sPAP > 0.3 ➡️Prognostic implications of RV remodelling need to be studied

Latest data on multivalve disease in #TTVR at #PCRLV⬆️ @PamelaGatto @alcantaramonica @dr_chrisallen @O_Azizy_MD @BenekiEirini @MiChen__ @juliendreyfus1 @jcecharte @DrGarot @cvnurselin @drtsakamoto @a_sorropago @TagliariPaula @m_taramasso @dr_tyxiong

🚀Additional insights from TRISCEND + TRISCEND II #treatTR: Multivalve disease in #TTVR by @JennifervStein et al. ⭐Find the key takes of the study in the @PCRonline #PCRLV e-Poster⤵️